Investment news

Changing healthcare forever and funding the new longevity economy

Our CEO and founder defines the domains of longevity, maps longevity’s component parts and spotlights future progress. Longevity Week 2022 was a week jam-packed with longevity-related symposia, conferences and get-togethers;…

Tick, tock… funding calls for both aging clocks and psychedelics and longevity grant proposals

Longevity Science Foundation is funding research that will establish a longer and healthier human lifespan The Longevity Science Foundation, which has committed $1 billion over the next ten years to…

Cajal Neuroscience launches with $96 million to transform neurodegeneration drug discovery

Financing led by Column Group and Lux Capital will aim to to accelerate neurodegeneration drug discovery by enabling target discovery and validation at unprecedented scale. Cajal Neuroscience, a biotechnology company…

Occuity lands £343k grant to develop optical diabetes screening device

British MedTech eyes non-invasive screening of diabetes in non-clinical settings. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the company featured in this article to support…

RxCelerate acquires Methuselah Health – launches “world-beating” proteomics service

Next-gen proteomics tech made available to the biotech and pharmaceutical industry through the acquisition of Methuselah by leading R&D services provider, RxCelerate. RxCelerate, an international out-sourced drug discovery and development…

Juvena Therapeutics bags $41 million to accelerate biologics for age-related diseases

Funding will power Juvena’s AI-enabled drug discovery platform to map the therapeutic potential of secreted proteins. Juvena Therapeutics, a biotech start-up scaling a computational platform to map the therapeutic potential…

The lifespan revolution is upon us – get involved and get ahead

Be involved and invested in the greatest investment opportunity of all time – longevity. November heralds mists, mellow fruitfulness… and longevity. Yup, Longevity Week is back and with it the…

Insilico Medicine signs $1.2 billion strategic research collaboration with Sanofi

Six-compound drug discovery collaboration will leverage cutting-edge AI tech. Insilico Medicine, a clinical stage AI-driven drug discovery company, has announced a multi-year, multi-target strategic research collaboration with pharma and healthcare…

Marc P Bernegger – making longevity tangible for everybody as soon as possible

Marc P Bernegger discusses building a bridge between amazing lab-based research and the creation of a successful longevity company. Over the last couple of weeks, we’ve brought you a series…